The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study
- PMID: 30659312
- PMCID: PMC6420609
- DOI: 10.1007/s00005-019-00534-9
The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study
Abstract
The aim of the study was to assess the activity of fucoidan on the uterine sarcomas (MES-SA and ESS-1) and carcinosarcoma cell lines (SK-UT-1 and SK-UT-1B) and its toxicity on the human skin fibroblasts (HSF). Two uterine sarcomas and two carcinosarcoma cell lines were examined, as a control HSF were used. Cell viability was assessed with MTT test, apoptosis with caspase-3 activity and cell cycle by assessment of DNA synthesis. Fucoidan significantly decreases cell viability in SK-UT-1, SK-UT-1B, and ESS-1 cell lines, such effect was not observed in MES-SA. Fucoidan was not substantially affecting proliferation among normal cells. The tested agent induced apoptosis in all cell cultures used in the experiment. Fucoidan affects cell cycle of all tested cell lines except MES-SA by increasing percentage of cells in G0/sub-G1/G1 phase. Fucoidan do not only affect proliferation but induces apoptosis in selected uterine sarcoma and carcinosarcoma cell lines, so it has potential to be used as cytotoxic agent. Fucoidan seems to be promising anti-cancer agent for endometrial stromal sarcoma and carcinosarcoma.
Keywords: Fucoidan; Targeted treatment; Uterine sarcomas.
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this paper.
Figures



Similar articles
-
Gemcitabine and Selected mTOR Inhibitors in Uterine Sarcomas and Carcinosarcoma Cells- an Isobolographic Analysis.Int J Med Sci. 2020 Oct 18;17(18):2987-2997. doi: 10.7150/ijms.48187. eCollection 2020. Int J Med Sci. 2020. PMID: 33173419 Free PMC article.
-
Genistein Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms.Anticancer Res. 2015 Jun;35(6):3167-73. Anticancer Res. 2015. PMID: 26026076
-
2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth.Gynecol Oncol. 2003 Nov;91(2):299-308. doi: 10.1016/s0090-8258(03)00542-0. Gynecol Oncol. 2003. PMID: 14599859
-
Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):773-82. doi: 10.1016/j.bpobgyn.2011.06.003. Epub 2011 Jul 14. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21752717 Review.
-
Adjuvant chemotherapy in early stage uterine sarcomas: an open question.Eur J Gynaecol Oncol. 2001;22(5):352-7. Eur J Gynaecol Oncol. 2001. PMID: 11766739 Review.
Cited by
-
Comparison of the Effects of Fucoidans on the Cell Viability of Tumor and Non-Tumor Cell Lines.Mar Drugs. 2019 Jul 26;17(8):441. doi: 10.3390/md17080441. Mar Drugs. 2019. PMID: 31357497 Free PMC article.
-
Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin.Int J Mol Sci. 2020 Apr 19;21(8):2848. doi: 10.3390/ijms21082848. Int J Mol Sci. 2020. PMID: 32325867 Free PMC article.
-
Isobolographic Analysis Demonstrates the Additive and Synergistic Effects of Gemcitabine Combined with Fucoidan in Uterine Sarcomas and Carcinosarcoma Cells.Cancers (Basel). 2019 Dec 31;12(1):107. doi: 10.3390/cancers12010107. Cancers (Basel). 2019. PMID: 31906221 Free PMC article.
-
Gemcitabine and Selected mTOR Inhibitors in Uterine Sarcomas and Carcinosarcoma Cells- an Isobolographic Analysis.Int J Med Sci. 2020 Oct 18;17(18):2987-2997. doi: 10.7150/ijms.48187. eCollection 2020. Int J Med Sci. 2020. PMID: 33173419 Free PMC article.
-
Assessment of Anticancer Properties of Argemone mexicana L. and Berberine: A Comparative Study.Plants (Basel). 2024 May 15;13(10):1374. doi: 10.3390/plants13101374. Plants (Basel). 2024. PMID: 38794444 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous